“An E-Medicine Delivery and Treatment Monitoring Service For Patients With Heart Disease In The NHS” - Project proposal ISSN 2753-8176 (online) (DOI:10.13140/RG.2.2.34395.03360) - References
1.Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P. Intern Emerg Med. 2017 Mar;12(2):147-155.
2. Rapid and Sensitive Detection of Cardiac Troponin I for Point-of-Care Tests Based on Red Fluorescent MicrospheresYanxue Cai, Keren Kang, Qianru Li, Yu Wang, Xiaowei He
Molecules. 2018 May; 23(5): 1102
3. How to choose a point-of-care testing for troponin.Lin YH, Zhang Y, Liu YT, Cui K, Kang JS, Zhou Z.J Clin Lab Anal. 2020 Jul;34(7):e23263.
4. Pedro A. (2020) The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Pre-prints, doi: 10.20944/preprints202007.0541.v1
5. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis. Austen El-Osta, Maria Woringer, Elena Pizzo, Talitha Verhoef, Claire Dickie, Melody Z Ni, Jeremy R Huddy, Michael Soljak, George B Hanna, Azeem MajeedBMJ Open. 2017; 7(8): e015494.
6. Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: A Health Technology Assessment [Internet].CADTH Optimal Use Report, No. 5.1b.
Ho C, Cimon K, Weeks L, et al. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar.
7. Contemporary point of care cardiac troponin testing in suspected acute coronary syndrome.Chapman AR, Stewart S, Mills NL. Heart. 2019 May;105(10):740-741.
8.Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting
Samuel S Allemann,Kurt E Hersberger,and Isabelle Arnet. Integr Pharm Res Pract. 2015; 4: 167–174.
9. Patients Perspectives on Automated Multi-dose Drug Dispensing. Bardage C and Ring L. Community Med Health 2016,
6:1
10. The Assessment, Monitoring, and Enhancement of Treatment Fidelity In Public Health Clinical Trials. Borreli B. J Public Health Dent. 2011 WINTER; 71(s1): S52–S63.
11. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. Kvarnström K, Airaksinen M, Liira H.BMJ Open. 2018 Jan 23;8(1):e015332. doi: 10.1136/bmjopen-2016-015332.
12. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. Mandeep Sekhon, Martin Cartwright, Jill J Francis. BMC Health Serv Res. 2017 Jan 26;17(1):88.
13. A Primer on Effectiveness and Efficacy Trials. Amit G Singal, Peter D R Higgins, and Akbar K Waljee. Clin Transl Gastroenterol. 2014 Jan; 5(1): e45.
14. Eliciting adverse effects data from participants in clinical trials. Elizabeth N Allen, Clare IR Chandler, Nyaradzo Mandimika, Cordelia Leisegang, Karen Barnes. Cochrane Systematic Review – Methodology, Version published: 16 January 2018
15. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis. Austen El-Osta, Maria Woringer, Elena Pizzo, Talitha Verhoef, Claire Dickie, Melody Z Ni, Jeremy R Huddy, Michael Soljak, George B Hanna, Azeem MajeedBMJ Open. 2017; 7(8): e015494.
Comments
Post a Comment